Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Up 7.9% in September

Spectral Medical Inc. (OTCMKTS:EDTXF) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 100,000 shares, a growth of 7.9% from the September 15th total of 92,700 shares. Based on an average daily volume of 35,900 shares, the short-interest ratio is currently 2.8 days.

Spectral Medical Price Performance

Spectral Medical stock opened at $0.42 on Friday. The stock has a 50-day moving average price of $0.47 and a 200 day moving average price of $0.40. The company has a market capitalization of $116.92 million, a price-to-earnings ratio of -8.34 and a beta of 0.93. Spectral Medical has a 52 week low of $0.22 and a 52 week high of $0.55.

Spectral Medical (OTCMKTS:EDTXF) last announced its quarterly earnings data on Friday, August 9th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.34 million for the quarter.

About Spectral Medical

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.